The Role of Stem Cells on Immune Cells in the Development of Cardiovascular Diseases
- Conditions
- AtherosclerosisCardiovascular Diseases
- Registration Number
- NCT03172507
- Lead Sponsor
- Radboud University Medical Center
- Brief Summary
An observational pilot proof-of-principle study. 15 patients with significant coronary artery disease and 15 matched controls. To investigate whether long-term activation of the innate immune system, named 'trained innate immunity', occurs at the level of the bone marrow progenitor cells in patients with significant coronary artery disease and whether this correlates with the proinflammatory phenotype of monocytes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 27
- Age ≥18 and ≤75 years
- With or without significant coronary artery disease on CCTA
- Written informed consent
- Chronic infections
- Diabetes mellitus
- Medical history of any disease associated with immune deficiency
- Clinically significant infections within 3 months prior to study entry
- Recent hospital admission or surgery with general anaesthesia
- Known chronic kidney or liver disease
- Previous vaccination within 3 months prior to study entry
- Inability to personally provide written informed consent
- Inability to undergo PET-CT scanning
- Chronic use of anti-inflammatory drugs such as NSAIDs
- History of haematological malignant disease
- Documented bleeding diathesis or thrombocytopenia
- Pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Phenotypical characteristics of HSPC's Study day 2 for patients Phenotypical characteristics of HSPC's populations of patients with and without significant coronary artery disease by flowcytometry in percentages.
Cytokine response of circulating monocytes Study day 2 for patients Cytokine response of monocytes of patients with and without significant coronary artery disease after 24 hour stimulation with several stimuli measured in cytokine levels.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Department of cardiology, CWZ
🇳🇱Nijmegen, Gelderland, Netherlands
Department of cardiology, Radboudumc
🇳🇱Nijmegen, Gelderland, Netherlands